ZYBT — Zhengye Biotechnology Holding Cashflow Statement
0.000.00%
Last trade - 00:00- $441.69m
- $460.63m
- CNY186.36m
Annual cashflow statement for Zhengye Biotechnology Holding, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 46.5 | 55.7 | 37.5 | 13.5 |
| Depreciation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | 3.55 | 10.9 | 6.72 | 3.47 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -33.7 | -66.8 | -20.5 | -0.977 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Taxes Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 31.8 | 17.3 | 48.2 | 41 |
| Capital Expenditures | -26.4 | -27.3 | -11.6 | -27.8 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 0.128 | 0 | -0.165 | 0.108 |
| Sale of Fixed Assets | ||||
| Purchase of Investments | ||||
| Cash from Investing Activities | -26.3 | -27.3 | -11.8 | -27.7 |
| Financing Cash Flow Items | 0 | 0 | -4.5 | -3.37 |
| Other Financing Cash Flow | ||||
| Total Cash Dividends Paid | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -3.05 | 13.5 | -19 | -22.1 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 2.49 | 3.46 | 17.4 | -8.58 |